TECHVISION
832876
JING JU LIN
873305
Jing-Jin Electric Technologies
688280
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
US Stock MarketDetailed Quotes
IOBT IO Biotech
- 1.140
- +0.120+11.76%
Close May 5 16:00 ET
75.10MMarket Cap-0.79P/E (TTM)
1.170High1.010Low231.29KVolume1.030Open1.020Pre Close251.85KTurnover0.74%Turnover RatioLossP/E (Static)65.88MShares1.73052wk High1.60P/B35.66MFloat Cap0.66052wk Low--Dividend TTM31.28MShs Float17.880Historical High--Div YieldTTM15.69%Amplitude0.660Historical Low1.088Avg Price1Lot Size
IO Biotech Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -14.79%-82.35M | 13.91%-19.63M | -30.13%-20.81M | 7.01%-16.98M | -69.72%-24.93M | -20.10%-71.74M | -81.98%-22.8M | -19.79%-15.99M | -40.36%-18.26M | 29.52%-14.69M |
| Net income from continuing operations | -10.93%-95.49M | -19.67%-31.33M | -10.78%-24.02M | 2.32%-20.69M | -14.16%-19.46M | -20.47%-86.08M | -30.45%-26.18M | -38.19%-21.68M | -14.51%-21.18M | 0.93%-17.04M |
| Operating gains losses | 1,184.29%3.59M | 1,252.35%4.67M | -576.61%-1.63M | 1,000.00%90K | 279.07%462K | -154.62%-331K | 22.41%-405K | 293.10%342K | -103.51%-10K | -1,390.00%-258K |
| Depreciation and amortization | 12.30%849K | 8.96%219K | 5.67%205K | 14.44%214K | 21.26%211K | 40.00%756K | 5.79%201K | 63.03%194K | 1,600.00%187K | -20.91%174K |
| Change In working capital | -62.81%2.18M | 155.19%5.19M | 36.32%2.95M | 57.58%1.76M | -1,502.73%-7.72M | 39.84%5.86M | -66.83%2.03M | 910.49%2.16M | -70.89%1.12M | 110.00%550K |
| -Change in prepaid assets | -154.72%-858K | 187.08%1.14M | 352.41%846K | -195.12%-760K | -210.21%-2.08M | -65.75%1.57M | -237.11%-1.31M | -91.71%187K | -68.10%799K | 266.23%1.89M |
| -Change in payables and accrued expense | -24.40%3.71M | 25.95%3.41M | 10.45%2.32M | 475.22%2.67M | -1,190.63%-4.69M | 2,514.78%4.9M | -39.98%2.71M | 184.72%2.1M | -77.29%464K | 91.52%-363K |
| -Change in other current assets | -625.00%-29K | 3.33%806K | -318.18%-48K | 135.71%5K | 0.00%-792K | 90.91%-4K | 8.94%780K | 0.00%22K | 98.19%-14K | -8,700.00%-792K |
| -Change in other current liabilities | -5.79%-639K | -13.89%-164K | -15.60%-163K | -17.16%-157K | 16.22%-155K | -334.53%-604K | -200.00%-144K | -98.59%-141K | -343.64%-134K | -146.67%-185K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -14.79%-82.35M | 13.91%-19.63M | -30.13%-20.81M | 7.01%-16.98M | -69.72%-24.93M | -20.10%-71.74M | -81.98%-22.8M | -19.79%-15.99M | -40.36%-18.26M | 29.52%-14.69M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 86.38%-44K | 90.18%-11K | 58.33%-10K | 69.23%-12K | 92.57%-11K | 53.19%-323K | 67.91%-112K | 79.66%-24K | 63.55%-39K | -27.59%-148K |
| Net PPE purchase and sale | 86.38%-44K | 90.18%-11K | 58.33%-10K | 69.23%-12K | 92.57%-11K | 53.19%-323K | 67.91%-112K | 79.66%-24K | 63.55%-39K | -27.59%-148K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 86.38%-44K | 90.18%-11K | 58.33%-10K | 69.23%-12K | 92.57%-11K | 53.19%-323K | 67.91%-112K | 79.66%-24K | 63.55%-39K | -27.59%-148K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 71.86M | -10K | ||||||
| Net common stock issuance | --0 | --0 | ---- | ---- | ---- | --75.06M | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---3.2M | ---10K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --0 | --0 | --71.86M | ---10K | --71.87M | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 0.42%143.46M | -51.47%80.45M | -8.47%101.02M | -8.19%118.25M | 0.42%143.46M | -32.55%142.86M | 9.46%165.77M | -35.23%110.36M | -31.55%128.8M | -32.55%142.86M |
| Current changes in cash | -41,095.50%-82.39M | 14.32%-19.64M | -137.27%-20.82M | 7.14%-16.99M | -68.10%-24.94M | 99.67%-200K | -78.00%-22.92M | 514.79%55.86M | -39.51%-18.3M | 29.21%-14.84M |
| Effect of exchange rate changes | -196.01%-771K | -185.06%-518K | 156.89%256K | -83.97%-241K | -134.58%-268K | 109.42%803K | -85.83%609K | 91.80%-450K | 97.19%-131K | 129.06%775K |
| End cash Position | -57.97%60.3M | -57.97%60.3M | -51.47%80.45M | -8.47%101.02M | -8.19%118.25M | 0.42%143.46M | 0.42%143.46M | 9.46%165.77M | -35.23%110.36M | -31.55%128.8M |
| Free cash flow | -14.34%-82.39M | 14.28%-19.64M | -30.00%-20.82M | 7.14%-16.99M | -68.10%-24.94M | -19.27%-72.06M | -77.92%-22.91M | -18.92%-16.01M | -39.51%-18.3M | 29.21%-14.84M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025